The SMARCA4R1157WM Mutation Facilitates Chromatin Remodeling and Confers PRMT1/SMARCA4 Inhibitors Sensitivity in Colorectal Cancer

Researchers showed that the SMARCA4R1157WM mutant reinforced the transcriptional expression of EGFR and TNS4 to promote the proliferation of colorectal cancer cells and patient-derived tumor organoids.
[NPJ Precision Oncology]
Full Article

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News